Skip to content

DreamStation DreamStation Auto CPAP, ARRecalls & reported problems

Respironics, Inc. · DreamStation Auto CPAP, Argentina · Class 2

All models of Philips DreamStation (190)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00606959048003), received between Aug 6, 2021 and Aug 6, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Contamination” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Contamination1
  • Degraded1

Patient problems

  • Chest Pain1
  • Eye Irritation1
  • Headache1
  • Nausea1
  • No Clinical Signs, Symptoms or Conditions1
  • Unspecified Respiratory Problem1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 6, 2021Degraded; Contamination; Degraded

    THE MANUFACTURER RECEIVED INFORMATION ALLEGING AN ISSUE RELATED TO A CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICE'S SOUND ABATEMENT FOAM. THERE WAS NO REPORT OF PATIENT HARM OR INJURY. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.

    Patient problems: Chest Pain; Eye Irritation; Headache; Nausea; No Clinical Signs, Symptoms or Conditions; Unspecified Respiratory Problem

    MAUDE report 12291371 ↗

Other VENTILATOR, NON-CONTINUOUS (RESPIRATOR) devices

All VENTILATOR, NON-CONTINUOUS (RESPIRATOR) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page